Concourse Financial Group Securities, Inc. Biocept Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.56 Billion
  • Q2 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.24 - $0.62 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.47 - $0.89 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.75 - $1.2 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.88 - $2.27 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.83 - $3.97 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$3.43 - $4.22 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$3.39 - $4.34 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$4.03 - $5.07 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$4.74 - $7.94 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$4.31 - $6.16 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$3.61 - $11.4 $0 - $0
0 New
0 $0

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email